Study guide

22.2 Seizures and PRES

Certified Pediatric Hematology Oncology Nurse CPHON®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy

2 Care Continuum

2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship

3 Leukemias and Lymphomas

3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas

4 CNS, Neuroblastoma, and Renal Tumors

4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors

5 Sarcomas and Other Solid Tumors

5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors

6 Hematologic Disorders

6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure

7 Pathophysiology, Genetics, and Diagnostics

7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis

8 Clinical Trials and Professional Performance

8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education

9 Chemotherapy and Biotherapy

9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy

10 Immunotherapy, Cellular Therapy, and Radiation

10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam

11 HSCT, Surgery, Transfusion, and Coagulation Therapy

11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy

12 Neurologic, Respiratory, and Cardiovascular Effects

12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects

13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects

13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects

14 Endocrine, Hematologic, Immunologic, and Sensory Effects

14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects

15 Pain, Sleep, Fatigue, and Mental Health

15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects

16 Supportive Care

16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care

17 Infectious and Gastrointestinal Emergencies

17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction

18 Metabolic Emergencies

18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome

19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome

19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)

20 Sickle Cell and Hemostasis Emergencies

20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed

21 Cardiopulmonary Emergencies

21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias

22 Neurologic and Infusion Emergencies

22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation

23 Family, Caregivers, and Social Integration

23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment

24 Development, Grief, Culture, and Community Resources

24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources

22.2 Seizures and PRES

Key Takeaways Explain This Topic AI

Oncology seizures come from electrolytes (sodium, calcium), CNS disease, methotrexate, ifosfamide, high-dose busulfan, and ICANS—not from “hospital anxiety” until those maps are cleared.

First actions are ABCs, a benzodiazepine per PALS or hospital protocol, airway protection, and immediate glucose plus sodium and calcium checks.

High-dose busulfan used in HSCT conditioning is epileptogenic and needs protocol seizure prophylaxis; a missed prophylaxis dose is a preventable seizure.

PRES is hypertension plus immunosuppression (calcineurin inhibitors, corticosteroids) with headache, visual change, and seizures; MRI shows posterior T2 hyperintensity.

PRES is often reversible if blood pressure is treated and the offending drug is held or adjusted with the team; do not wait for a routine MRI if the child is seizing and hypertensive.

Last updated: August 2026

CPHON TCO V.F.2–3 tests seizures and posterior reversible encephalopathy syndrome (PRES) as neurologic emergencies. This is not the chronic vincristine-neuropathy or school-504 lecture. It is also not a demand that you recite one society’s exact milligram-per-kilogram benzodiazepine table as if ONCC printed it. The product is a nurse who protects the airway , gives a benzodiazepine per Pediatric Advanced Life Support (PALS) or hospital protocol, checks glucose and electrolytes, and names the oncology trigger—including PRES—before anyone files the event as “just a febrile seizure.”

A 5-year-old who seizes during high-dose methotrexate , a 12-year-old day +18 after hematopoietic stem cell transplantation (HSCT) on tacrolimus who goes blind then convulses, and a 9-year-old after CD19 chimeric antigen receptor T-cell (CAR-T) therapy who cannot name a pencil and then seizes are three different maps that share the same first minute.

Why children on this unit seize

High-yield pediatric oncology causes:

Electrolytes: falling sodium (SIADH, water load, cerebral salt wasting) and low calcium (tumor lysis, massive transfusion citrate, hungry-bone pictures). The metabolic-emergency chapter owns the chemistry; this chapter owns the convulsion.

CNS disease: new or residual brain tumor, hemorrhage, infection, leukoencephalopathy, drop in perfusion.

Methotrexate , intrathecal or high-dose intravenous , can produce acute neurotoxicity that includes seizure or a stroke-like picture. Hold further methotrexate and notify; this is not “attention-seeking.”

Ifosfamide encephalopathy includes confusion, hallucinations, cerebellar signs, and seizures during or hours after the infusion. Stop the remaining drug; methylene blue as ordered lives with the neurologic-effects chapter. The emergency here is still airway and benzodiazepines if the child is convulsing.

Busulfan , especially high-dose conditioning for HSCT, is epileptogenic . Protocol seizure prophylaxis (often levetiracetam ; older pathways used phenytoin) is part of the conditioning checklist. A missed prophylaxis dose is a preventable seizure, not a surprise. Teach families that the “anti-seizure medicine with the chemo” is not optional.

ICANS after CAR-T or T-cell–engaging antibodies: delirium, aphasia, seizure, cerebral edema. ICE-style checks and corticosteroids belong with cellular therapy; if the child is seizing, ABCs and benzodiazepines still go first.

Do not invent a single ONCC-mandatory glucose number. Do check glucose, because hypoglycemia is a fixable cause. Do not force objects into the mouth. Time the event. Protect from injury. Stay until the motor activity stops or the airway team takes over.

First actions: ABCs, benzodiazepines, labs

Airway, breathing, circulation first. Position to protect the airway, suction if needed, give oxygen, and do not leave a post-ictal child supine and unwatched with a full stomach. Benzodiazepines are first-line for ongoing seizure per PALS and the hospital status-epilepticus pathway (commonly intravenous lorazepam when a line is working; midazolam intramuscular, intranasal, or buccal when it is not). Use the protocol in front of you; do not delay the first dose to debate brand names. Repeat per protocol if the seizure continues. Escalate to the next-line antiseizure medicine and intensive care rather than stacking uncounted benzodiazepine syringes on the floor.

Draw glucose , sodium , and calcium (and a blood gas, complete blood count, and drug levels the team orders) as soon as you can without delaying the benzodiazepine. Correct hypoglycemia. Hyponatremic seizure is an intensive-care hypertonic-saline problem from the metabolic chapter, not more free water. Hypocalcemic tetany and seizure need calcium as ordered, with the tumor-lysis caution if phosphate is extreme.

Walk the 5-year-old during high-dose methotrexate: four minutes of generalized shaking, oxygen saturation falling, no line in the playroom. Intramuscular or intranasal midazolam per protocol, airway, glucose, sodium, calcium, notify, seizure precautions, hold the next methotrexate until the team images and decides. Do not walk the child back to the playroom because “it stopped.” Do not wait for a routine electroencephalogram tomorrow while the child is still blue.

PRES: hypertension, immunosuppression, reversible if caught

PRES is a clinicopathologic syndrome: endothelial injury and vasogenic edema, classically in posterior parietal-occipital white matter. The pediatric oncology cluster is hypertension plus immunosuppression . High-yield drugs: calcineurin inhibitors ( tacrolimus , cyclosporine ) after HSCT or solid-organ pathways, and corticosteroids . Other reported associations include selected chemotherapy and sudden blood-pressure spikes. Do not treat one brand as the only 2026 cause.

What you see: severe headache , visual change (blurred vision, cortical visual loss, photopsias), altered mental status, and seizures —often in a child whose blood pressure is well above that child’s baseline. A 12-year-old on tacrolimus whose usual systolic pressure is 100 mm Hg and who now reads 168/110 mm Hg with “I cannot see the television” is PRES until imaging says otherwise. Magnetic resonance imaging (MRI) classically shows posterior T2 / fluid-attenuated inversion recovery hyperintensity . Treat the child in front of you; do not withhold blood-pressure control and antiseizure care until the scanner is free.

Treatment: protect airway if seizing; benzodiazepines as above; treat hypertension with the agents the team orders—bring the pressure down in a controlled way, not a crash to shock; hold or adjust the offending drug with the transplant or oncology team . Do not unilaterally discard a graft-protecting calcineurin inhibitor in the hallway, and do not double the tacrolimus because “visual change means rejection.” Caught early, PRES is often reversible . Missed, it becomes infarction, refractory seizures, or herniation. Serial neurologic checks after the first seizure are the intervention, not a single normal pupil chart.

Distinguish look-alikes. ICANS is an immune-effector window after CAR-T or bispecifics; steroids and ICE-style exams dominate, and tocilizumab is not the automatic first drug for isolated aphasia. Methotrexate leukoencephalopathy is timed to IT or high-dose methotrexate. Stroke and CNS relapse still need imaging. Meningitis remains on the differential after HSCT, but a hypertensive, cortically blind child on tacrolimus is PRES first, not an automatic LP through a tight brain. If mass effect is in play, the last section’s LP ban still holds.

  • Trigger Clock First nursing move Then
  • Low sodium or calcium Chemistry crash ABCs, benzodiazepine, replace as ordered Seizure precautions
  • Methotrexate During or after IT or high-dose IV ABCs, hold MTX, notify Imaging, neuro checks
  • Ifosfamide Infusion window Stop infusion; ABCs if seizing Methylene blue as ordered

High-dose busulfan HSCT conditioning Give protocol prophylaxis; treat a seizure as status until it stops Do not skip the prophylaxis dose

ICANS Days after CAR-T or bispecific ABCs, benzodiazepine, ICE-style checks Corticosteroids per protocol

PRES Hypertension plus calcineurin inhibitor or steroids ABCs, treat BP, hold or adjust drug with team MRI posterior T2; often reversible

The CPHON product for TCO V.F.2–3 is a benzodiazepine that did not wait for an electroencephalogram, a glucose and sodium that left with the first blood draw, a busulfan prophylaxis dose that was actually given, and a hypertensive, visually changing HSCT patient who was named PRES before anyone doubled the tacrolimus.

Loading diagram... Seizure first minute, then name the oncology map including PRES